Abstract: Iodinated contrast agents, such as iopamidol, are worldwide employed for performing a number of X-ray diagnostic procedures. Every year, thousands of tons of iodinated contrast agents are manufactured for the market with chemical processes that usually employ thionyl chloride. In this paper, we describe two new green approaches to iopamidol that avoid or reduce the use of this noxious reagent.
INTRODUCTION
Nowadays, the most commonly used iodinated contrast agents are non-ionic, water-soluble aromatic molecules containing three atoms of iodine, an element with high X-ray attenuation [1] .
In particular, 5-acylamino-2,4,6-triiodo-1,3-benzenedicarboxamides are compounds widely employed in medicine as X-ray contrast agents since they are able to improve the images obtained with routinely used diagnostic procedures such as angiography, urography, and computed tomography [2] [3] [4] . These compounds have a very low toxicity, are not metabolized in humans, and are completely eliminated unchanged by renal excretion [5, 6] . It has been estimated that more than 80 million contrastenhanced X-ray scans are performed worldwide each year, and this means that well above 5000 tons of iodinated contrast agents are manufactured [7] .
Iopamidol 1 (Scheme 1), patented in 1974, was the first non-ionic X-ray contrast agent to give rise to stable aqueous formulations. It was the pioneer molecule in this field and still is one of the most employed worldwide [8] [9] [10] .
The current manufacturing process for iopamidol 1 is shown in Scheme 1 and involves the iodination of 5-amino-1,3-benzenedicarboxylic acid 2 with a solution of iodine monochloride in hydrochloric acid [11] . The triododerivative 3 is then chlorinated with thionyl chloride to give, via the not isolated sulfinyl intermediate 4 [12] , the acyl chloride 5, which is reacted with (S)-2-acetoxypropanoyl chloride 6 [13] in N,N-dimethylacetamide. Derivative 7 is then amidated with an excess of 2-amino-1,3-propanediol (commonly named serinol) 8, and the intermediate 9 is finally hydrolyzed with sodium hydroxide to give iopamidol 1.
The above process, with some modifications, has been used since the early 1980s. Nevertheless, the replacement of some of the toxic and hazardous reagents with more benign ones would be important from an environmental point of view. The iodination reaction to give 3, for example, is performed with ICl, which is obtained by direct oxidation of iodine with chlorine while the production of 5 needs thionyl chloride. The latter is also employed for the synthesis of 6 from lactic acid 10 (Scheme 2).
Thionyl chloride is a low-cost and versatile reagent [14] [15] [16] [17] [18] [19] , widely employed in organic syntheses performed at laboratory or industrial scale. It is the reagent of choice for the preparation of acid chlorides [20] , and the procedure usually involves heating the carboxylic acid with an excess of thionyl chloride neat or dissolved in an inert solvent. Usually, a catalyst, such as pyridine or N,N-dimethylformamide, is employed to promote the reaction. Heating at the boiling point of the solvent speeds the reaction to completion by removal of the volatile by-products, HCl and SO 2 . For a laboratory preparation this is not a problem, provided that the reaction is performed under a well-ventilated fume cupboard. At industrial scale, this is a drawback since the gaseous stream must be efficiently treated in a scrubber with an alkaline solution, producing a consistent amount of salts.
Moreover, thionyl chloride has several safety problems because it is a very corrosive and reactive reagent. It causes severe skin burns, eye damage, and respiratory tract injury if the vapors are inhaled. It reacts violently with water, generating hydrogen chloride and sulfur dioxide, both irritating for the respiratory system. Since thionyl chloride is a precursor for a chemical weapon such as mustard gas, its production, commercial sale, and export are regulated under the international chemical weapons treaty [16] .
In this article, we describe two new approaches to iopamidol that have been developed with the aim to largely decrease the use of thionyl chloride and to reduce the amount of related wastes, according to the principles and the philosophy of green chemistry [21] [22] [23] .
ALTERNATIVE PROCESSES

Smiles rearrangement
A different process for the production of iopamidol was studied and developed trying to mimic the synthesis of iomeprol 19 (Scheme 3), another X-ray contrast agent manufactured by Bracco [24, 25] . It is worth briefly recalling the iomeprol synthetic path as it is a real green process. Indeed, apart from the first two steps performed in n-butanol, the rest of the synthesis is run in water. The crucial step is the final Smiles rearrangement [26] [27] [28] , which consists of the migration of the substituted phenyl ring from one heteroatom (O) to the other (N), the latter being part of a secondary amide.
The initial part of the iopamidol synthesis via Smiles rearrangement (Scheme 4) exactly follows Scheme 3, provided that serinol 8 is used in place of isoserinol 14 [29] . In comparison with the synthetic path of Scheme 1, there are two advantages: (i) the elimination of thionyl chloride since the carboxamide moieties are prepared through ester groups and (ii) the iodination in a later stage, which allows a significant saving of the expensive iodine monochloride. 
Mixed process
Again, the crucial point for a new process was the elimination of the acyl chlorides in the preparation of the carboxamide moieties. According to the literature, 5-nitro-1,3-benzenedicarboxylic acid 24 can be esterified, amidated with serinol, and then the nitro group reduced to amino to give the key intermediate 26 (Scheme 5) [30, 31] .
Safety studies performed by us showed that the intermediate nitroamide 25 has some stability problems when heated at a temperature near the one of reaction, and, for this reason, we decided to still rely on 5-amino-1,3-benzenedicarboxylic acid 2 (Scheme 6).
The carboxylic groups of 2 are transformed into either methyl 27a or n-butyl 27b diesters by esterification with the corresponding alcohol and p-toluenesulfonic acid (PTSA). Diester 27b is preferred because the water formed in the reaction can be easily removed by distillation of the azeotrope with n-butanol. The subsequent amidation to 26 is performed in methanol using sodium methoxide as the catalyst and close to stoichiometric amounts of serinol. This is a great advantage in comparison with the current process where serinol is also used as the proton acceptor in the amidation step, thus making recovery of excess serinol compulsory due to the high cost of such starting material. Diamide 26 nicely crystallizes from the reaction mixture. The iodination of the aromatic ring in 26 is performed as in the current process with a solution of iodine monochloride in hydrochloric acid. Again, the introduction of iodine in a late stage of the synthesis allows a significant saving of this expensive starting material. The selective acylation of the aniline group of 28 with compound 6 was unsuccessful due to similar reactivity of the hydroxy groups. Accordingly, the latter are selectively protected as acetates by reaction with acetic anhydride using 4-dimethylaminopyridine (DMAP) as the catalyst [32] , followed by acylation of the aniline group with 6. The final hydrolysis with NaOH of all the acetoxy groups affords iopamidol 1 with good yield (Scheme 6) [33] .
